C92.91
Myeloid leukemia, unspecified in remission
Clinical Classification Guidelines
Medical Intelligence & Overview
Myeloid leukemia, unspecified in remission, is a type of blood cancer that affects the myeloid cells in the bone marrow. It is characterized by the uncontrolled growth of abnormal white blood cells, which can interfere with the production of healthy blood cells. The term 'in remission' indicates that all detectable signs of the disease have been temporarily reduced or disappeared following treatment. This condition can be complex and requires ongoing monitoring by healthcare professionals to manage and detect any potential recurrence.
Causes & Symptoms
Clinical Causes: Genetic mutations within myeloid cells Previous exposure to radiation or chemotherapy Family history of leukemia or other blood disorders Certain genetic disorders such as Down syndrome Environmental factors like exposure to benzene or other chemicals
Key Symptoms: Fatigue and weakness Unusual or excessive bleeding and bruising Frequent infections Unintended weight loss Fever or night sweats Bone pain or tenderness Pale skin and anemia-related symptoms
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a combination of blood tests and bone marrow examinations. Common methods include:
Treatment Protocols: Treatment options for myeloid leukemia in remission focus on maintaining remission, minimizing the risk of relapse, and managing any ongoing health issues. Typically, management strategies include:
Clinical Advice & FAQs
Billing Guidance
Is C92.91 a billable ICD-10 code?
Yes, C92.91 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C92.91?
Clinical documentation must specify the nature of Myeloid leukemia, unspecified in remission and any associated comorbidities for accurate reporting.
Cite this Clinical Reference